The FDA’s approval of a new painkiller has raised alarms nationwide, as critics warn it could be dangerously addictive. There is big controversy tonight involving a new narcotic painkiller that goes on the market next month. It is drawing a lot of opposition over concerns that it could be dangerously addictive and add to the fatal overdoses from prescription drugs. The company that makes it maintains it is safe. We get more on that from our chief medical examiner, Nancy Snyderman.
View the full interview here.
Follow us on Twitter